These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9229177)

  • 1. Predisposing factors to spondyloarthropathies.
    Brown M; Wordsworth P
    Curr Opin Rheumatol; 1997 Jul; 9(4):308-14. PubMed ID: 9229177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility genes and ankylosing spondylitis.
    Reveille JD
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):601-9. PubMed ID: 16777585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic aspects of ankylosing spondylitis.
    Khan MA; Ball EJ
    Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):675-90. PubMed ID: 12406434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic basis of ankylosing spondylitis.
    Reveille JD
    Curr Opin Rheumatol; 2006 Jul; 18(4):332-41. PubMed ID: 16763451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of HLA B27 in diagnosis of seronegative spondyloarthropathies.
    Sonkar GK; Usha
    Indian J Pathol Microbiol; 2007 Oct; 50(4):908-13. PubMed ID: 18306603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spondyloarthritis: update on pathogenesis and management.
    Reveille JD; Arnett FC
    Am J Med; 2005 Jun; 118(6):592-603. PubMed ID: 15922688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis.
    Marcilla M; López de Castro JA
    Tissue Antigens; 2008 Jun; 71(6):495-506. PubMed ID: 18489433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B27 and other predisposing factors in spondyloarthropathies.
    Khare SD; Luthra HS; David CS
    Curr Opin Rheumatol; 1998 Jul; 10(4):282-91. PubMed ID: 9725088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related disparities: influence of environmental factors.
    Olden K; White SL
    Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of the spondyloarthropathies.
    Woodrow JC
    Curr Opin Rheumatol; 1991 Aug; 3(4):586-91. PubMed ID: 1911054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-B27 MHC associations of ankylosing spondylitis.
    Sims AM; Barnardo M; Herzberg I; Bradbury L; Calin A; Wordsworth BP; Darke C; Brown MA
    Genes Immun; 2007 Mar; 8(2):115-23. PubMed ID: 17167495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the genetics of spondyloarthritis--ankylosing spondylitis and psoriatic arthritis.
    Chandran V; Rahman P
    Best Pract Res Clin Rheumatol; 2010 Oct; 24(5):579-88. PubMed ID: 21035081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis.
    Maksymowych WP; Tao S; Vaile J; Suarez-Almazor M; Ramos-Remus C; Russell AS
    J Rheumatol; 2000 Jan; 27(1):183-9. PubMed ID: 10648037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why is the concept of spondyloarthropathies important?
    Dougados M; Hochberg MC
    Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):495-505. PubMed ID: 12406423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of ankylosing spondylitis: current concepts.
    Smith JA; Märker-Hermann E; Colbert RA
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):571-91. PubMed ID: 16777583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients.
    González S; Torre-Alonso JC; Martínez-Borra J; Fernández Sánchez JA; López-Vazquez A; Rodríguez Pérez A; López-Larrea C
    J Rheumatol; 2001 Jun; 28(6):1288-93. PubMed ID: 11409121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms.
    Thorsby E; Lie BA
    Transpl Immunol; 2005 Aug; 14(3-4):175-82. PubMed ID: 15982560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extraskeletal manifestations of seronegative spondyloarthropathies].
    Morović-Vergles J
    Reumatizam; 2004; 51(2):19-21. PubMed ID: 15554372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigens in undifferentiated spondyloarthritis.
    Liao HT; Lin KC; Chen CH; Liang TH; Lin MW; Tsai CY; Tak Yan Yu D; Chou CT
    Semin Arthritis Rheum; 2007 Dec; 37(3):198-201. PubMed ID: 17604825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: infection and spondyloarthritis.
    Inman RD
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):163-9. PubMed ID: 16932676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.